RT @Yash25571056: As to 308 Covid-19 patients, 72.4% developed Olfactory dysfunctions (ODs) such as complete anosmia (57.8%) and troposmia…
RT @Yash25571056: As to 308 Covid-19 patients, 72.4% developed Olfactory dysfunctions (ODs) such as complete anosmia (57.8%) and troposmia…
RT @Yash25571056: As to 308 Covid-19 patients, 72.4% developed Olfactory dysfunctions (ODs) such as complete anosmia (57.8%) and troposmia…
RT @Yash25571056: As to 308 Covid-19 patients, 72.4% developed Olfactory dysfunctions (ODs) such as complete anosmia (57.8%) and troposmia…
RT @Yash25571056: As to 308 Covid-19 patients, 72.4% developed Olfactory dysfunctions (ODs) such as complete anosmia (57.8%) and troposmia…
RT @Yash25571056: As to 308 Covid-19 patients, 72.4% developed Olfactory dysfunctions (ODs) such as complete anosmia (57.8%) and troposmia…
RT @Yash25571056: As to 308 Covid-19 patients, 72.4% developed Olfactory dysfunctions (ODs) such as complete anosmia (57.8%) and troposmia…
As to 308 Covid-19 patients, 72.4% developed Olfactory dysfunctions (ODs) such as complete anosmia (57.8%) and troposmia (8.4%). Those were significantly related to increased prevalence of diabetes, hypertension asthma, etc. https://t.co/uKuVmKFNXz